Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-EMA head Thomas Lönngren must wait two years before joining pharma firms

This article was originally published in Scrip

Executive Summary

Thomas Lönngren, the former head of the European Medicines Agency (EMA), will probably have to relinquish all or some of the commercial appointments that he has taken up since his departure from the agency. EMA said on 21 March that Mr Lönngren must wait two years before he takes up a position with the private sector pharmaceutical industry. The announcement follows controversy over a potential conflict of interest after Mr Lönngren joined private sector companies shortly after leaving the EMA.

Topics

Related Companies

UsernamePublicRestriction

Register

SC012324

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel